- Tebipenem
-
- $15.00 / 1KG
-
2021-07-13
- CAS:161715-21-5
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Tebipenem
-
- $15.00 / 1KG
-
2021-07-10
- CAS:161715-21-5
- Min. Order: 1KG
- Purity: 99%+ HPLC
- Supply Ability: Monthly supply of 1 ton
- Tebipenem
-
- $1.00 / 1KG
-
2019-07-06
- CAS:161715-21-5
- Min. Order: 1G
- Purity: 98%
- Supply Ability: 100KG
|
| | Tebipenem Basic information |
| Product Name: | Tebipenem | | Synonyms: | Tebipenem;(4R,5S,6S)-3-[[1-(4,5-Dihydro-2-thiazolyl)-3-azetidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid;LJC 11036;LJC11036;LJC-11036;Tebipenem Impurity 5;Tebipenem USP/EP/BP;(4R,5S,6S)-3-[1-(4,5-dihydro-1,3-thiazol-2-yl)azetidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicaci | | CAS: | 161715-21-5 | | MF: | C16H21N3O4S2 | | MW: | 383.49 | | EINECS: | | | Product Categories: | API | | Mol File: | 161715-21-5.mol |  |
| | Tebipenem Chemical Properties |
| Boiling point | 624.5±65.0 °C(Predicted) | | density | 1.75 | | storage temp. | Sealed in dry,Store in freezer, under -20°C | | solubility | insoluble in EtOH; ≥19.15 mg/mL in H2O with gentle warming; ≥24.9 mg/mL in DMSO | | form | solid | | pka | 4.29±0.60(Predicted) | | color | White to khaki |
| | Tebipenem Usage And Synthesis |
| Biological Activity | tebipenem is an orally available carbapenem antibiotic. tebipenem is active against a panel of clinical isolates from a variety of bacterial species (mic50s ≤ 0.0039 ~ 8 μg/ml), including methicillin-resistant strains of staphylococcus aureus (s. aureus) and staphylococcus epidermidis (s. epidermidis), as well as penicillin-resistant streptococcus pneumoniae (s. pneumonia). tebipenem also inhibits β-lactamase in a time- and concentration-dependent manner. tebipenem pivoxil, a derivative of tebipenem, has been under development as the first orally available carbapenem antibiotic for the treatment of respiratory and otolaryngological infections caused by drug-resistant s. pneumonia in pediatric patients.1. hazra s, xu h, blanchard js. tebipenem, a new carbapenem antibiotic, is a slow substrate that inhibits the β-lactamase from mycobacterium tuberculosis. biochemistry, 2014, 53(22): 3671-3678.2. fujimoto k, takemoto k, hatano k, et al. novel carbapenem antibiotics for parenteral and oral applications: in vitro and in vivo activities of 2-aryl carbapenems and their pharmacokinetics in laboratory animals. antimicrobial agents and chemotherapy, 2013, 57(2): 697-707. |
| | Tebipenem Preparation Products And Raw materials |
|